fda_recall · drug_recall · high
Breckenridge Pharmaceutical, Inc. — Class II recall: Duloxetine Delayed-Release Capsules, USP, 60mg, packaged in a) 90 Capsules (NDC…
- Event date
- 2026-06-17 00:00:00Z
- Observed
- 2026-07-09 22:51:35Z
- Source ID
- D-0583-2026
- Payload hash
- 7c69d7d0246eaf6269eacd39…
Summary
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit Status: Ongoing.
Informational only. Not legal, financial, or medical advice.